1. Home
  2. NAVI vs EVO Comparison

NAVI vs EVO Comparison

Compare NAVI & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Navient Corporation

NAVI

Navient Corporation

HOLD

Current Price

$8.63

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.09

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAVI
EVO
Founded
1973
1993
Country
United States
Germany
Employees
N/A
4766
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NAVI
EVO
Price
$8.63
$3.09
Analyst Decision
Sell
Strong Buy
Analyst Count
7
1
Target Price
$12.14
$7.00
AVG Volume (30 Days)
1.0M
145.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
7.42%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$82.46
N/A
Revenue Next Year
$12.45
$7.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.36
$2.84
52 Week High
$16.07
$4.80

Technical Indicators

Market Signals
Indicator
NAVI
EVO
Relative Strength Index (RSI) 22.71 33.68
Support Level N/A $2.87
Resistance Level $13.34 $3.78
Average True Range (ATR) 0.34 0.09
MACD 0.01 -0.05
Stochastic Oscillator 16.00 14.29

Price Performance

Historical Comparison
NAVI
EVO

About NAVI Navient Corporation

Navient Corp provides technology-enabled education finance solutions that simplify complex programs and help millions of people achieve success. The company operates its business in three segments: Federal Education Loans, Consumer Lending, and Business Processing. A majority of its revenue is generated from the Federal Education Loans segment, in which the company owns and manages the Federal Family Education Loan Program (FFELP) loans, generating revenue mainly in the form of net interest income. The Consumer Lending segment owns and manages private education loans and is the master servicer for these portfolios. Through its Earnest brand, the company also refinances and originates in-school private educational loans.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: